{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:52:33Z","timestamp":1781722353469,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004605","name":"Zhengzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["252102311220"],"award-info":[{"award-number":["252102311220"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bioorg.2025.109233","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T22:07:46Z","timestamp":1763590066000},"page":"109233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery of novel aniline-pyrimidine analogues as orally bioavailable dual VEGFR-2\/tubulin inhibitors with potent antitumor and anti-angiogenesis efficacy"],"prefix":"10.1016","volume":"167","author":[{"given":"Yanan","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moran","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2025.109233_bb0005","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109233_bb0010","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","article-title":"NF-\u03baB in inflammation and cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"13","key":"10.1016\/j.bioorg.2025.109233_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33662","article-title":"Development of a novel prognostic signature for colorectal cancer based on angiogenesis-related genes","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109233_bb0020","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1038\/s41598-025-87459-w","article-title":"To construct and validate a risk score model of angiogenesis-related genes to predict the prognosis of hepatocellular carcinoma","volume":"15","author":"Gao","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109233_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189079","article-title":"VEGF signaling: role in angiogenesis and beyond","volume":"1879","author":"Shaw","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109233_bb0030","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1002\/ptr.7023","article-title":"Antiangiogenic properties of lichen secondary metabolites","volume":"35","author":"Ulus","year":"2021","journal-title":"Phytother. Res."},{"issue":"17","key":"10.1016\/j.bioorg.2025.109233_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174177","article-title":"Convection-enhanced delivery of antiangiogenic drugs and liposomal cytotoxic drugs to heterogeneous brain tumor for combination therapy","volume":"14","author":"Bhandari","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2025.109233_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128941","article-title":"Radiosynthesis and evaluation of [(11)C]AG-488, a dual anti-angiogenetic and anti-tubulin PET ligand","volume":"74","author":"Dileep Kumar","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109233_bb0045","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1021\/acs.jmedchem.3c02399","article-title":"Discovery of novel Isoquinoline analogues as dual tubulin polymerization\/V-ATPase inhibitors with immunogenic cell death induction","volume":"67","author":"Leng","year":"2024","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109233_bb0050","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1158\/0008-5472.CAN-23-3332","article-title":"CENP-E inhibition induces chromosomal instability and synergizes with diverse microtubule-targeting agents in breast Cancer","volume":"84","author":"Tucker","year":"2024","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109233_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ph16050749","article-title":"S-72, a novel orally available tubulin inhibitor, overcomes paclitaxel resistance via inactivation of the STING pathway in breast Cancer","volume":"16","author":"Hou","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109233_bb0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.20517\/cdr.2022.90","article-title":"Multimodal 4-arylchromene derivatives with microtubule-destabilizing, anti-angiogenic, and MYB-inhibitory activities","volume":"6","author":"K\u00f6hler","year":"2023","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.bioorg.2025.109233_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106684","article-title":"Tubulin degradation: principles, agents, and applications","volume":"139","author":"Zhang","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109233_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216617","article-title":"Evolution and contemporary role of metronomic chemotherapy in the treatment of neuroblastoma","volume":"588","author":"Chou","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2025.109233_bb0075","article-title":"A phase II clinical study on Apatinib plus vinorelbine in refractory HER2-negative breast cancer and its metabolic implications of drug resistance","author":"Wu","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bioorg.2025.109233_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108713","article-title":"Discovery of novel flavonoid derivatives targeting VEGFR2 and tubulin with potent anticancer efficacy","volume":"163","author":"He","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109233_bb0085","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1021\/ml4004793","article-title":"Discovery of antitubulin agents with antiangiogenic activity as single entities with multitarget chemotherapy potential","volume":"5","author":"Gangjee","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109233_bb0090","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11030-023-10603-z","article-title":"New antiproliferative 3-substituted oxindoles inhibiting EGFR\/VEGFR-2 and tubulin polymerization","volume":"28","author":"Ezelarab","year":"2024","journal-title":"Mol. Divers."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109233_bb0095","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1021\/acs.jmedchem.8b01391","article-title":"Design, synthesis, and biological evaluation of 6-substituted Thieno[3,2- d]pyrimidine analogues as dual epidermal growth factor receptor kinase and microtubule inhibitors","volume":"62","author":"Romagnoli","year":"2019","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109233_bb0100","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1039\/D3MD00128H","article-title":"Synthesis and anti-hepatocellular carcinoma evaluation of salicylic acid-modified indole trimethoxy flavonoid derivatives","volume":"14","author":"Zou","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109233_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113948","article-title":"Novel pyrazolo[3,4-d]pyrimidines as potential anticancer agents: synthesis, VEGFR-2 inhibition, and mechanisms of action","volume":"156","author":"Ruzi","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109233_bb0110","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/ml1001568","article-title":"Discovery of dual VEGFR-2 and tubulin inhibitors with in vivo efficacy","volume":"1","author":"Chekler","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109233_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107679","article-title":"Discovery of novel amide derivatives against VEGFR-2\/tubulin with potent antitumor and antiangiogenic activity","volume":"151","author":"Liu","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109233_bb0120","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12935-024-03415-0","article-title":"Key genes and molecular mechanisms related to paclitaxel resistance","volume":"24","author":"Alalawy","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109233_bb0125","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.18632\/aging.102842","article-title":"Identification of a lathyrane-type diterpenoid EM-E-11-4 as a novel paclitaxel resistance reversing agent with multiple mechanisms of action","volume":"12","author":"Liu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bioorg.2025.109233_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.dnarep.2021.103243","article-title":"Recent advances in gamma H2AX biomarker-based genotoxicity assays: a marker of DNA damage and repair","volume":"108","author":"Rahmanian","year":"2021","journal-title":"DNA Repair"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109233_bb0135","first-page":"4450","article-title":"The c-Jun NH(2)-terminal protein kinase\/AP-1 pathway is required for efficient apoptosis induced by vinblastine","volume":"61","author":"Fan","year":"2001","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109233_bb0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbrc.2009.01.032","article-title":"p21 functions in a post-mitotic block checkpoint in the apoptotic response to vinblastine","volume":"380","author":"Bene","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109233_bb0145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41568-023-00656-5","article-title":"Linking cell mechanical memory and cancer metastasis","volume":"24","author":"Cambria","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109233_bb0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/0115665240254765231117122210","article-title":"ADGRL4 promotes cell growth, aggressiveness, EMT, and angiogenesis in neuroblastoma via activation of ERK\/STAT3 pathway","volume":"25","author":"Geng","year":"2025","journal-title":"Curr. Mol. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109233_bb0155","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s11010-022-04579-x","article-title":"Immunohistochemical expressions of EMT markers in pan-RAS-pERK1\/2-positive tumors improve diagnosis and prognosis assessment of non-muscle invasive bladder cancer and muscle invasive bladder cancer patients","volume":"478","author":"Tripathi","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bioorg.2025.109233_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122563","article-title":"VEGF\/VEGFR axis and its signaling in melanoma: current knowledge toward therapeutic targeting agents and future perspectives","volume":"345","author":"Malekan","year":"2024","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109233_bb0165","first-page":"143","article-title":"AttenhERG: a reliable and interpretable graph neural network framework for predicting hERG channel blockers","volume":"16","author":"Yang","year":"2024","journal-title":"J. Chemother."},{"key":"10.1016\/j.bioorg.2025.109233_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129205","article-title":"Synthesis and biological evaluation of N-(3-fluorobenzyl)-4-(1-(methyl-d(3))-1H-indazol-5-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-amine as a novel, potent ALK5 receptor inhibitor","volume":"85","author":"Kang","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109233_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100716","article-title":"Creation of a novel zebrafish model with low DHA status to study the role of maternal nutrition during neurodevelopment","volume":"66","author":"Ranard","year":"2025","journal-title":"J. Lipid Res."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109233_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073283","article-title":"Exploring multi-target therapeutic strategies for glioblastoma via endogenous network modeling","volume":"26","author":"Yao","year":"2025","journal-title":"Int. J. Mol. Sci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T23:01:25Z","timestamp":1766098885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825011137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":36,"alternative-id":["S0045206825011137"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109233","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel aniline-pyrimidine analogues as orally bioavailable dual VEGFR-2\/tubulin inhibitors with potent antitumor and anti-angiogenesis efficacy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109233"}}